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Lead toxicity is one of the most studied
environmental health issues and is also the
most outstanding example of how knowl-
edge learned from research can impact pub-
lic health. The National Institute of
Environmental Health Sciences (NIEHS)
has provided support for many ofthe basic
studies over the past 30 years, resulting in
advances in understanding cellular effects of
lead and effects on organ systems. Many of
these accomplishments have been summa-
rized in the NIEHS-sponsored conferences
published in Environmental Health
Perspectives (1) and in other published
reports (2-4).
Research Accomplishments
The most significant research accomplish-
ments have concerned effects of low-level
exposures to lead on cognitive and behavioral
development ofyoung children. The 1992
World Health Organization/International
Program forChemical SafetyTask Group on
Effects of Inorganic Lead concluded that
blood lead levels in young children generally
below 25 pg/dl are associated with a reduc-
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Figure 1. Blood lead levels in children 1-5 years of age in the United States as measured by NHANES II in
1976-1980 (A) versus blood lead levels as measured in children by NHANES 1II, 1988-1991 (B). From Pirkle
et al.( 15).
the general population of all ages decreased
by 78%, from 12.8 to 2.8 jig/dl between
1976 and 1991, and 77% for children ages
1-5 years, from 15 pg/dl to 3.6 pg/dl.
In spite of measures reducing lead
exposure to date, large numbers ofchildren
in the United States have high exposure to
lead and are at risk for impaired cognitive
and behavioral development.
Continuing Risks to Lead Exposure
andToxicity
Many ofthe most important risk factors are
low income and socioeconomic status,
houses containing lead-based paint, and
poor nutrition. In a 1988 report to
Congress, the Agency for Toxic Substances
and Disease Registry (ATSDR) determined
that about 10% ofthe 1 million or so black
children that live in inner city areas oflarge
U.S. cities and have an income below the
poverty level have blood lead levels greater
than 15 pg/dl (15). Children who live in
old houses with lead-containing paint and
exposure to lead-containing dust are at
increased risk for lead exposure and elevated
blood lead levels. Lead was banned from
indoor paint in the United States in 1978,
so every house built before that time is like-
ly to contain lead-based paint. This includes
more than 50 million dwellings (3). It is
estimated that at least 6 million children
live in houses built prior to 1940-houses
that constitute the greatest risk.
Less-than-ideal nutrition contributes to
adverse consequences of lead exposure, par-
ticularly diets that are deficient in the essen-
tial minerals calcium, iron, and zinc, (16).
Studies with experimental animals fed diets
low in calcium have established that calcium
deficiency increases both tissue retention and
toxicity of lead (17). Iron deficiency also
increases tissue deposition and toxicty to lead
(18). A high prevalance of iron deficiency
occurs in infants and children because ofthe
need to expand the body's iron pool during
growth; it has been observed that the chil-
dren with the highest environmental expo-
sures to lead are also at the greatest risk to
iron deficiency (19). The most significant
health impact ofiron deficiency is in young
children who develop defects in attention
span that lead to learning deficits (20). A
longitudinal prospective study in Yugoslavia
showed that both lead exposure and iron
deficiency produce effects on neurobehavior
and the hemopoietic system among pregnant
women, infants, and children (21). Lead and
zinc interactions are not as well defined as
those between lead and calcium and between
lead and iron. Experimental studies have
shown that lead increases zinc excretion (22)
and that zinc deficiency enhances lead
absorption (23). There is also a close inverse
relationship between blood lead levels and
zinc-containing heme enzymes (24).
Prenatal Exposures to Lead
Risk factors for prenatal exposure to lead
involve maternal exposure and body bur-
den oflead. There are both exogenous and
endogenous factors contributing to mater-
nal blood lead levels and in utero exposure
to the fetus. Several studies have shown
that there is no impairment to lead crossing
the placenta and that maternal and fetal
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Figure 2. Plot of time course of maternal blood
lead (geometric mean and SE) during pregnancy
for subjects with complete and incomplete data.
Incomplete data are offset on the X-axis for clari-
ty. Upward trend of complete subjects from 20
weeks to term is significant. Ranges of horizontal
lines above the data indicate significant compar-
isons using least significant differences post-hoc
test, with indicated probabilities. Conversion fac-
tor for blood lead is 10.0 pg/dl = 0.48 pmol/l. From
Rothenberg et al. (26).
blood lead levels are similar (25). Today in
the United States, environmental exposure
to lead is largely from dietary sources for
non-occupationally exposed women but, in
areas of the world where leaded gasoline is
still in use, airborne lead may be a signifi-
cant source. Lead-glazed pottery from cot-
tage industries may also be a potential
source where such pottery is in use.
Gastrointestinal absorption of lead may be
increased during pregnancy along with
increased calcium absorption.
The major endogenous source oflead is
the skeletal system. Lead in bone reflects
past exposure and may be independent of
blood lead. The increase in the calcium
requirement during pregnancy is accompa-
nied by release oflead into blood which, in
turn, results in fetal exposure to lead. An
interesting demonstration of changes in
blood lead levels during pregnancy was
recently reported for 105 women living in
Mexico City (26). The mean blood lead
level for the group was 7.0 pg/dl with a
range of 1.3-35.5 pig/dl, (Fig. 2). There is a
significant decrease in blood lead level
between 12 and 20 weeks (1.1 pg/dl). This
has been explained by physiological factors
such as increase in organ size and hemodi-
lution. From week 20 to delivery, there is a
linear upward trend.
Studies using stable isotope techniques
have shown that about 45-75% of lead in
blood is derived from bone lead in persons
without excessive exposure to lead (27,28),
and there is 'a further 32%-65% increase in
the contribution of skeletal lead to blood
lead during gestation (B.L. Gulson, person-
al communication). The wide variation is
thought to be due to differences in the
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ratio ofbone lead to blood lead in specific
individuals. It is expected that low dietary
calcium will result in greater mobilization
of bone calcium, and lead along with the
calcium is contributed to supply needs of
the fetus.
Central Nervous System and Birth
Outcomes from Prenatal Exposure to
Lead
Assessment of cognitive development in
relation to prenatal exposure to lead is diffi-
cult because of limitations in assessment
methodology. Nevertheless, results of
prospective epidemiological studies (29,30)
have shown that children with high umbili-
cal cord blood lead (>10 pg/dl) have a slow-
er sensorimotor or visual-motor develop-
ment as measured by the Bayley Scales of
Infant Development than children with
lower blood lead levels at birth. Deficits in
cognitive development with increased pre-
natal blood lead levels are likely to attenuate
over time. Blood lead levels at 24 months of
age have been found to be the most predic-
tive of future cognitive development.
Bellinger et al. (29) found that persistence
of the cognitive deficit related to prenatal
lead exposure is most often detected in
those infants with either high postnatal
exposure or less than optimal socioeconom-
ic demographics.
Andrews et al. (31) reviewed 25 epi-
demiological studies to determine the rela-
tionship of prenatal lead exposure and
birth outcomes. They concluded that pre-
natal lead exposure is unlikely to increase
the risk of premature rupture of mem-
branes but does appear to increase the risk
of preterm delivery. It is unclear whether
prenatal lead exposure decreases gestational
age. Prenatal lead exposure appears to be
related to reduced birth weight, but results
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Figure 3. Relationship between brain weight and
brain lead content in 21 human fetuses with matu-
rities of 14-40 weeks. From Barltrop (34).
vary in relation to study design and degree
ofcontrol for confounding factors.
Exposure ofFetal Brain to Lead
Experimental studies have shown that the
fetal blood-brain barrier is immature and
uptake oflead by fetal rat brain during ges-
tation is greater than after birth. There is a
sixfold increase in total brain lead prenatal-
ly compared to a 3.5-fold increase during
weaning and a twofold increase post-wean-
ing with the same level of exposure (32).
As animals mature, less lead enters the
brain. Other experimental studies suggest
that the immature endothelial cells forming
the capillaries of the developing brain are
less resistant to the effects oflead than cap-
ilaries from mature brains; these immature
endothelial cells permit fluid and cations
induding lead to reach newly formed com-
ponents ofthe brain, particularly astrocytes
and neurons (33).
There are few studies ofuptake oflead
by the human brain during development.
The largest number of lead measurements
in fetal brain have been reported by
Barltrop (34) in 21 human fetuses with
maturities of 14-40 weeks, (Fig. 3). There
was a direct relationship between brain
weight and brain lead content, but there
was no change in lead concentration. There
was also a parallel increase in calcium; it
has been suggested that movement oflead
into the fetal brain, as well as other tissues,
follows the movement of calcium. Studies
in guinea pigs have shown that transfer of
lead from mother to fetus is linearly related
to umbilical cord blood flow rate (35).
Mechanisms forNeurological Effects
ofLead
Clinical and experimental studies have pro-
vided insights regarding the mechanisms
whereby lead produces neurological effects
on the developing brain as studied postna-
tally (36). Mechanisms for neurological
effects as studied postnatally arelikely to be
a continuum ofprenatal effects; however, it
is not known whether there are unique pre-
natal neurological effects.
Effects oflead on the developing brain
arebothmorphological andpharmacological.
*Neuropharmacological
-Lead substitutes forcalcium
-Neurotransmitter Release
-Protein kinase C
-Na-CaATPase
-Energymetabolism
*Neurodevelopmental (morphological)
-Interference with adhesion molecules
-Impaired programming of cell:cell
connections
-Miswiring of central nervous system
(CNS).
One ofthe principal mechanisms by which
the central nervous system develops during
the early postnatal period is by overgrowth
of neuronal processes, with subsequent
"pruning" or deletion ofsynapses to adjust
to the needs of its environment. For
humans more brain development occurs
after birth than in any other species. A
highly significant morphological effect is
the result oflead impairment oftimed pro-
gramming ofcell:cell connections resulting
in modification ofneuronal circuitry (37).
This effect has been shown to be the result
ofdecreased sialic acid production by neur-
al cells, which produces a failure in synaptic
structuring (38). This disruption of the
toning or matching process of neuronal
connections or "miswiring" may produce
functional effects. It has also been found
that lead induces precocious differentiation
ofthe glia upon which cells migrate to their
eventual positions during structuring ofthe
brain, further enhancing the likelihood of
alterations in normal development (39).
Lead functions pharmacologically by
interfering with synaptic mechanisms for
neurotransmitter release. It has been sug-
gested that lead can substitute for calcium
and possibly zinc in ion-dependent events
at the synapse and is responsible for the
observed impairment by lead of various
neurotransmitter systems (cholinergic,
GABergic, and dopaminergic) (36,40).
The neonatal period has been found to be
most sensitive to inhibitory action of lead
on N-methyl-D-aspartate receptor-ion
function channels (41). In vitro studies on
brain capillaries have shown that micromo-
lar concentrations of lead activate protein
kinase C, a second messenger in the regula-
tion ofcellular metabolism (42). Lead may
also replace calcium in calmodulin-depen-
dent reactions, inhibit membrane-bound
Na+, K@-ATPase, and interfere with mito-
chondrial release of calcium with impair-
ment of energy metabolism (43). These
effects are potentially reversible iflead can
be removed from active sites. Although
removal from lead exposure and chelation
therapy lower blood lead levels, there is lit-
tle or no information regarding effects
from removal of lead from these sensitive
molecular sites (44).
In spite of the demonstrated morpho-
logical and pharmacological effects of lead
in the maturing brain, it is difficult to
demonstrate a functional or clinical effect
in the child under 2 years ofage because of
the immaturity of the brain and limited
number of functions that can be tested at
that age. There is no consistent lead neu-
ropsychological syndrome or behavioral
signature that can be -identified clinically
(45). In some studies, lead is most closely
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related to loss inverbal skills; in others, it is
nonverbal skills. Studies ofcohorts ofchil-
dren with postnatal exposure to lead deter-
mined that the perceptual-motor subsets of
the McCarthy Scales ofChildren's Abilities
were particularly sensitive to lead exposure
(46). Lead related losses in visual motor
integration, poorer performance on tasks of
serial learning, and increased errors in tasks
requiring perseverance in experimatal ani-
mal models are generally consistent with
clinical findings and are thought to pin-
point the hippocampus as the primary tar-
get for neurobehavioral effects (47-50).
Also, the hippocampus is known to accu-
mulate lead in humans (51) and rat pups
exposed to lead (52). However, Lilienthal
et al. (53) found that the behavioral profile
in rats with chemically induced lesions of
the hippocampus differed from patterns
obtained in rats with prenatal exposure to
lead and that chemical lesions ofthe amyg-
dala show a greater similarity with lead-
induced effects, suggesting that the hip-
pocampus is not the sole target for lead
toxicity.
Summary
Advances in the understanding ofthe toxic
effects oflead is an outstanding example of
how knowledge learned from research can
impact public health. Reduction oflead in
gasoline, elimination of lead solder from
canned food, removal of lead from paint,
and abatement ofhousing containing lead-
based paint are important contributions to
reduction of lead exposure. Factors that
enhance risk to lead exposure, particularly
during fetal life, are low socioeconomic sta-
tus, old housing with lead-containing
paint, and less than ideal nutrition, particu-
larly low dietary intake of calcium, iron,
and zinc. Prenatal exposure may result
from endogenous sources such as lead in
the maternal skeletal system or maternal
exposures from diet and the environment.
The developing nervous system is par-
ticularly sensitive to the toxic effects of
lead, and experimental studies have shown
that a large number of the effects in the
nervous system are due to interference by
lead with biochemical functions dependent
on calcium ions and impairment of neu-
ronal connections dependent on dendritic
pruning.
In spite ofpast efforts, there are many
important avenues for further research,
particularly with regard to prenatal expo-
sures and neurological effects. Ongoing
studies using stable-isotope techniques
should provide new information regarding
maternal-fetal transfer of lead. There is
need for a better understanding of the
mechanisms for the toxic effect of lead on
the nervous system and also to determine
whether effects from postnatal exposure are
a continuum of prenatal lead exposure or
whether prenatal exposure to lead produces
unique effects.
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